Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

BIT:CRL - Euronext Milan - IT0005331019 - Common Stock - Currency: EUR

20.95  -0.15 (-0.71%)

Fundamental Rating

5

Overall CRL gets a fundamental rating of 5 out of 10. We evaluated CRL against 19 industry peers in the Building Products industry. While CRL has a great profitability rating, there are some minor concerns on its financial health. CRL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year CRL was profitable.
In the past year CRL had a positive cash flow from operations.
CRL had positive earnings in each of the past 5 years.
Each year in the past 5 years CRL had a positive operating cash flow.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.13%, CRL belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
The Return On Equity of CRL (12.67%) is better than 83.33% of its industry peers.
CRL has a Return On Invested Capital of 7.87%. This is in the better half of the industry: CRL outperforms 61.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRL is significantly above the industry average of 6.98%.
The 3 year average ROIC (14.00%) for CRL is well above the current ROIC(7.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 6.13%
ROE 12.67%
ROIC 7.87%
ROA(3y)8.96%
ROA(5y)9.07%
ROE(3y)26.92%
ROE(5y)25.46%
ROIC(3y)14%
ROIC(5y)13.44%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

CRL has a better Profit Margin (8.80%) than 100.00% of its industry peers.
In the last couple of years the Profit Margin of CRL has remained more or less at the same level.
CRL's Operating Margin of 11.43% is amongst the best of the industry. CRL outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of CRL has grown nicely.
CRL has a better Gross Margin (44.41%) than 72.22% of its industry peers.
CRL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.43%
PM (TTM) 8.8%
GM 44.41%
OM growth 3Y4.37%
OM growth 5Y3.35%
PM growth 3Y1%
PM growth 5Y-0.07%
GM growth 3Y-1.11%
GM growth 5Y4.26%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40 50

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRL is creating some value.
Compared to 1 year ago, CRL has more shares outstanding
CRL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRL has an improved debt to assets ratio.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

CRL has a debt to FCF ratio of 3.36. This is a good value and a sign of high solvency as CRL would need 3.36 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.36, CRL belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
A Debt/Equity ratio of 0.29 indicates that CRL is not too dependend on debt financing.
CRL's Debt to Equity ratio of 0.29 is amongst the best of the industry. CRL outperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.36
Altman-Z N/A
ROIC/WACC0.99
WACC7.92%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.3 Liquidity

CRL has a Current Ratio of 1.87. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Current ratio value of 1.87, CRL belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
A Quick Ratio of 1.25 indicates that CRL should not have too much problems paying its short term obligations.
CRL has a better Quick ratio (1.25) than 72.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.25
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

CRL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.34%.
CRL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.01% yearly.
Looking at the last year, CRL shows a very negative growth in Revenue. The Revenue has decreased by -24.95% in the last year.
The Revenue has been growing by 18.34% on average over the past years. This is quite good.
EPS 1Y (TTM)-31.34%
EPS 3Y27.16%
EPS 5Y18.01%
EPS Q2Q%-45.8%
Revenue 1Y (TTM)-24.95%
Revenue growth 3Y25.17%
Revenue growth 5Y18.34%
Sales Q2Q%-15.3%

3.2 Future

Based on estimates for the next years, CRL will show a small growth in Earnings Per Share. The EPS will grow by 3.79% on average per year.
Based on estimates for the next years, CRL will show a small growth in Revenue. The Revenue will grow by 5.10% on average per year.
EPS Next Y-33.32%
EPS Next 2Y-8.31%
EPS Next 3Y-0.13%
EPS Next 5Y3.79%
Revenue Next Year-10.77%
Revenue Next 2Y-0.56%
Revenue Next 3Y2.6%
Revenue Next 5Y5.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.54 indicates a quite expensive valuation of CRL.
Compared to the rest of the industry, the Price/Earnings ratio of CRL is on the same level as its industry peers.
When comparing the Price/Earnings ratio of CRL to the average of the S&P500 Index (29.35), we can say CRL is valued expensively.
A Price/Forward Earnings ratio of 35.98 indicates a quite expensive valuation of CRL.
Based on the Price/Forward Earnings ratio, CRL is valued a bit more expensive than 61.11% of the companies in the same industry.
CRL is valuated expensively when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 45.54
Fwd PE 35.98
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

77.78% of the companies in the same industry are cheaper than CRL, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CRL is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 46
EV/EBITDA 23.18
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of CRL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.53
EPS Next 2Y-8.31%
EPS Next 3Y-0.13%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.90%, CRL is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.35, CRL is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.33, CRL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.9%

5.2 History

The dividend of CRL decreases each year by -21.07%.
Dividend Growth(5Y)-21.07%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

41.33% of the earnings are spent on dividend by CRL. This is a bit on the high side, but may be sustainable.
DP41.33%
EPS Next 2Y-8.31%
EPS Next 3Y-0.13%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (3/7/2025, 7:00:00 PM)

20.95

-0.15 (-0.71%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-07 2024-11-07/dmh
Earnings (Next)03-13 2025-03-13/amc
Inst Owners31.3%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.36B
Analysts71.11
Price Target19.89 (-5.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.9%
Yearly Dividend0.17
Dividend Growth(5Y)-21.07%
DP41.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.49%
Min EPS beat(2)-9.99%
Max EPS beat(2)-0.99%
EPS beat(4)2
Avg EPS beat(4)8.45%
Min EPS beat(4)-9.99%
Max EPS beat(4)23.76%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.81%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)-4.42%
Revenue beat(4)1
Avg Revenue beat(4)-3.83%
Min Revenue beat(4)-6.54%
Max Revenue beat(4)0.83%
Revenue beat(8)5
Avg Revenue beat(8)10.17%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.7%
PT rev (3m)4.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)4.71%
EPS NY rev (3m)-4.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-3.11%
Valuation
Industry RankSector Rank
PE 45.54
Fwd PE 35.98
P/S 4.02
P/FCF 46
P/OCF 27.51
P/B 5.79
P/tB 78.07
EV/EBITDA 23.18
EPS(TTM)0.46
EY2.2%
EPS(NY)0.58
Fwd EY2.78%
FCF(TTM)0.46
FCFY2.17%
OCF(TTM)0.76
OCFY3.64%
SpS5.21
BVpS3.62
TBVpS0.27
PEG (NY)N/A
PEG (5Y)2.53
Profitability
Industry RankSector Rank
ROA 6.13%
ROE 12.67%
ROCE 9.99%
ROIC 7.87%
ROICexc 9.07%
ROICexgc 25.76%
OM 11.43%
PM (TTM) 8.8%
GM 44.41%
FCFM 8.74%
ROA(3y)8.96%
ROA(5y)9.07%
ROE(3y)26.92%
ROE(5y)25.46%
ROIC(3y)14%
ROIC(5y)13.44%
ROICexc(3y)18.85%
ROICexc(5y)18.64%
ROICexgc(3y)50.02%
ROICexgc(5y)43.62%
ROCE(3y)17.79%
ROCE(5y)17.52%
ROICexcg growth 3Y11.57%
ROICexcg growth 5Y14.49%
ROICexc growth 3Y-8.74%
ROICexc growth 5Y0.27%
OM growth 3Y4.37%
OM growth 5Y3.35%
PM growth 3Y1%
PM growth 5Y-0.07%
GM growth 3Y-1.11%
GM growth 5Y4.26%
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 3.36
Debt/EBITDA 1.12
Cap/Depr 90.26%
Cap/Sales 5.88%
Interest Coverage 9.23
Cash Conversion 81.5%
Profit Quality 99.32%
Current Ratio 1.87
Quick Ratio 1.25
Altman-Z N/A
F-Score5
WACC7.92%
ROIC/WACC0.99
Cap/Depr(3y)94.32%
Cap/Depr(5y)99.17%
Cap/Sales(3y)4.52%
Cap/Sales(5y)4.96%
Profit Quality(3y)82.03%
Profit Quality(5y)88.99%
High Growth Momentum
Growth
EPS 1Y (TTM)-31.34%
EPS 3Y27.16%
EPS 5Y18.01%
EPS Q2Q%-45.8%
EPS Next Y-33.32%
EPS Next 2Y-8.31%
EPS Next 3Y-0.13%
EPS Next 5Y3.79%
Revenue 1Y (TTM)-24.95%
Revenue growth 3Y25.17%
Revenue growth 5Y18.34%
Sales Q2Q%-15.3%
Revenue Next Year-10.77%
Revenue Next 2Y-0.56%
Revenue Next 3Y2.6%
Revenue Next 5Y5.1%
EBIT growth 1Y-48.47%
EBIT growth 3Y30.64%
EBIT growth 5Y22.3%
EBIT Next Year-5.57%
EBIT Next 3Y9.78%
EBIT Next 5Y10.17%
FCF growth 1Y98.55%
FCF growth 3Y19.47%
FCF growth 5Y52.55%
OCF growth 1Y86.04%
OCF growth 3Y21.34%
OCF growth 5Y30.01%